We are a leader in complex, high-quality medicines and we are committed to maintaining that position by cultivating talent and fostering a culture of ongoing learning. Reflecting on these efforts, we are excited to announce the successful launch of the third batch with 30 new members of our Amneal team for the Sterile Manufacturing course, under our AmNeev learning initiative. This course offers a unique blend of theoretical learning and hands-on experience, ensuring participants are industry-ready by the time they complete the program. During the launch, our Amneal leaders highlighted how this course is designed to meet the growing needs of sterile manufacturing by training professionals with the specialized skills required for this evolving field. We are also proud to share that the first two batches, comprising 60 members, are close to completing their training and will soon join the Amneal workforce in their entirety. Here's to building a stronger, more capable workforce together!
关于我们
Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Our family delivers for yours through a robust U.S. generics business, a growing branded business and deepening portfolios in injectables, biosimilars and select international markets. We’ve bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. And we invest substantially in our people through leadership development and employee well-being programs – all so we can deliver even more value. We are Amneal and We make healthy possible. Content is for informational purposes only and 3rd party content does not reflect Amneal’s opinions. Amneal has the right to remove comments that violate another’s copyright or intellectual property, mention an Amneal product, use profanity or are defamatory, promote and solicit for third-party sites, initiatives, or products, or are factually inaccurate or misleading or spam. Amneal recommends that you consult with your healthcare provider regarding personal health matters. To report a product complaint or adverse event related to an Amneal product, contact Drug Safety at 877-835-5472, option 3 or [email protected]. If you are currently experiencing a life-threatening event, please immediately contact 911.
- 网站
-
https://www.amneal.com
Amneal Pharmaceuticals的外部链接
- 所属行业
- 制药业
- 规模
- 5,001-10,000 人
- 总部
- Bridgewater，New Jersey
- 类型
- 上市公司
- 创立
- 2002
地点
-
主要
获取路线
400 Crossing Boulevard
US，New Jersey，Bridgewater，08807
Amneal Pharmaceuticals员工
动态
-
The U.S. FDA has awarded Amneal more Competitive Generic Therapy (CGT) product approvals than any other company since the FDA created the approval pathway. CGT designation is given when there is inadequate generic competition on the market for a specific drug. https://lnkd.in/dzfSDqp9?(Accessed November 19, 2024)
-
-
Watch Srinivas’ Voices of Leadership video here: https://lnkd.in/e7-vXha5
-
-
What enables us to make healthy possible? Is it the innovation in our labs, our reputation for world class research and quality, is it our obsession with delivering affordable medicines, or is it us? The answer is all of it. Important note - Amneal has three reportable business segments: 1) Generics (includes retail, injectables, biosimilars & international revenue), 2) Specialty and 3) AvKARE (includes distribution, government label and institutional revenue).
-
It’s #GlobalBiosimilarsWeek! This year's campaign is focused on advancing access to biosimilars- a commitment that our team is focused on every day.? Learn more: https://lnkd.in/d_cpUnQ
-
-
On behalf of our 7,800 global team members, we announced strong third quarter results today, including broad-based revenue growth across all three of our business segments: Generics, Specialty and AvKARE. As we execute our strategy, further diversify, and drive sustainable growth, we are building Amneal as a leading, diversified global pharmaceutical company. Please reference Amneal’s Third Quarter press release for more information, including non-GAAP financial measures, reconciliations and risks related to forward-looking statements: https://lnkd.in/ehZfceJz
-
We make high quality medicines more accessible, from our family to yours. Learn more: Amneal.com
-
-
Join a culture where innovation and quality fuel our purpose: Amneal.com/careers Some of our newest Endocrinology commercial team members just joined us in Bridgewater, New Jersey!
-
-
We value continuous improvement and employee expertise! Last week, our Brookhaven, New York manufacturing team hosted their first Kaizen Fest.? Our colleagues submitted 125+ ideas for ways we can do things better, faster and stronger.? 9 were selected to present to their peers and our global leaders, including Co-Founder and Co-CEO Chintu Patel, at this special event. Take a look at some of the photos!